Cargando…

Vaccination and Infection as Causative Factors in Japanese Patients With Rasmussen Syndrome: Molecular Mimicry and HLA Class I

Rasmussen syndrome is an intractable epilepsy with a putative causal relation with cellular and humoral autoimmunity. Almost half of the patients have some preceding causative factors, with infections found in 38.2%, vaccinations in 5.9% and head trauma in 8.9% of Japanese patients. In a patient wit...

Descripción completa

Detalles Bibliográficos
Autores principales: Takahashi, Yukitoshi, Matsuda, Kazumi, Kubota, Yuko, Shimomura, Jiro, Yamasaki, Etsuko, Kudo, Tatsuya, Fukushima, Katsuyuki, Osaka, Hitoshi, Akasaka, Noriyuki, Imamura, Atsushi, Yamada, Shinji, Kondo, Naomi, Fujiwara, Tateki
Formato: Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2006
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2270760/
https://www.ncbi.nlm.nih.gov/pubmed/17162382
http://dx.doi.org/10.1080/17402520600589522
_version_ 1782151756309856256
author Takahashi, Yukitoshi
Matsuda, Kazumi
Kubota, Yuko
Shimomura, Jiro
Yamasaki, Etsuko
Kudo, Tatsuya
Fukushima, Katsuyuki
Osaka, Hitoshi
Akasaka, Noriyuki
Imamura, Atsushi
Yamada, Shinji
Kondo, Naomi
Fujiwara, Tateki
author_facet Takahashi, Yukitoshi
Matsuda, Kazumi
Kubota, Yuko
Shimomura, Jiro
Yamasaki, Etsuko
Kudo, Tatsuya
Fukushima, Katsuyuki
Osaka, Hitoshi
Akasaka, Noriyuki
Imamura, Atsushi
Yamada, Shinji
Kondo, Naomi
Fujiwara, Tateki
author_sort Takahashi, Yukitoshi
collection PubMed
description Rasmussen syndrome is an intractable epilepsy with a putative causal relation with cellular and humoral autoimmunity. Almost half of the patients have some preceding causative factors, with infections found in 38.2%, vaccinations in 5.9% and head trauma in 8.9% of Japanese patients. In a patient with seizure onset after influenza A infections, cross-reaction of the patient's lymphocytes with GluRε2 and influenza vaccine components was demonstrated by lymphocyte stimulation test. Database analyses revealed that influenza A virus hemagglutinin and GluRε2 molecules contain peptides with the patient's HLA class I binding motif (HLA − A*0201). The relative risks of HLA class I genotypes for Rasmussen syndrome are 6.1 (A*2402), 6.4 (A*0201), 6.3 (A*2601) and 11.4 (B*4601). The relative risks of HLA class I-A and B haplotypes are infinity (A*2601+B*5401), 21.1 (A*2402+B*1501), 13.3 (A*2402+B*4801) and 5.1 (A*2402+B*5201). Some alleles and haplotypes of HLA class I may be the risk factors in Japanese patients. Cross-reactivity of cytotoxic T lymphocytes may contribute to the processes leading from infection to the involvement of CNS.
format Text
id pubmed-2270760
institution National Center for Biotechnology Information
language English
publishDate 2006
publisher Hindawi Publishing Corporation
record_format MEDLINE/PubMed
spelling pubmed-22707602008-03-31 Vaccination and Infection as Causative Factors in Japanese Patients With Rasmussen Syndrome: Molecular Mimicry and HLA Class I Takahashi, Yukitoshi Matsuda, Kazumi Kubota, Yuko Shimomura, Jiro Yamasaki, Etsuko Kudo, Tatsuya Fukushima, Katsuyuki Osaka, Hitoshi Akasaka, Noriyuki Imamura, Atsushi Yamada, Shinji Kondo, Naomi Fujiwara, Tateki Clin Dev Immunol Research Article Rasmussen syndrome is an intractable epilepsy with a putative causal relation with cellular and humoral autoimmunity. Almost half of the patients have some preceding causative factors, with infections found in 38.2%, vaccinations in 5.9% and head trauma in 8.9% of Japanese patients. In a patient with seizure onset after influenza A infections, cross-reaction of the patient's lymphocytes with GluRε2 and influenza vaccine components was demonstrated by lymphocyte stimulation test. Database analyses revealed that influenza A virus hemagglutinin and GluRε2 molecules contain peptides with the patient's HLA class I binding motif (HLA − A*0201). The relative risks of HLA class I genotypes for Rasmussen syndrome are 6.1 (A*2402), 6.4 (A*0201), 6.3 (A*2601) and 11.4 (B*4601). The relative risks of HLA class I-A and B haplotypes are infinity (A*2601+B*5401), 21.1 (A*2402+B*1501), 13.3 (A*2402+B*4801) and 5.1 (A*2402+B*5201). Some alleles and haplotypes of HLA class I may be the risk factors in Japanese patients. Cross-reactivity of cytotoxic T lymphocytes may contribute to the processes leading from infection to the involvement of CNS. Hindawi Publishing Corporation 2006 /pmc/articles/PMC2270760/ /pubmed/17162382 http://dx.doi.org/10.1080/17402520600589522 Text en Copyright © 2006 Hindawi Publishing Corporation. http://creativecommons.org/licenses/by/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Takahashi, Yukitoshi
Matsuda, Kazumi
Kubota, Yuko
Shimomura, Jiro
Yamasaki, Etsuko
Kudo, Tatsuya
Fukushima, Katsuyuki
Osaka, Hitoshi
Akasaka, Noriyuki
Imamura, Atsushi
Yamada, Shinji
Kondo, Naomi
Fujiwara, Tateki
Vaccination and Infection as Causative Factors in Japanese Patients With Rasmussen Syndrome: Molecular Mimicry and HLA Class I
title Vaccination and Infection as Causative Factors in Japanese Patients With Rasmussen Syndrome: Molecular Mimicry and HLA Class I
title_full Vaccination and Infection as Causative Factors in Japanese Patients With Rasmussen Syndrome: Molecular Mimicry and HLA Class I
title_fullStr Vaccination and Infection as Causative Factors in Japanese Patients With Rasmussen Syndrome: Molecular Mimicry and HLA Class I
title_full_unstemmed Vaccination and Infection as Causative Factors in Japanese Patients With Rasmussen Syndrome: Molecular Mimicry and HLA Class I
title_short Vaccination and Infection as Causative Factors in Japanese Patients With Rasmussen Syndrome: Molecular Mimicry and HLA Class I
title_sort vaccination and infection as causative factors in japanese patients with rasmussen syndrome: molecular mimicry and hla class i
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2270760/
https://www.ncbi.nlm.nih.gov/pubmed/17162382
http://dx.doi.org/10.1080/17402520600589522
work_keys_str_mv AT takahashiyukitoshi vaccinationandinfectionascausativefactorsinjapanesepatientswithrasmussensyndromemolecularmimicryandhlaclassi
AT matsudakazumi vaccinationandinfectionascausativefactorsinjapanesepatientswithrasmussensyndromemolecularmimicryandhlaclassi
AT kubotayuko vaccinationandinfectionascausativefactorsinjapanesepatientswithrasmussensyndromemolecularmimicryandhlaclassi
AT shimomurajiro vaccinationandinfectionascausativefactorsinjapanesepatientswithrasmussensyndromemolecularmimicryandhlaclassi
AT yamasakietsuko vaccinationandinfectionascausativefactorsinjapanesepatientswithrasmussensyndromemolecularmimicryandhlaclassi
AT kudotatsuya vaccinationandinfectionascausativefactorsinjapanesepatientswithrasmussensyndromemolecularmimicryandhlaclassi
AT fukushimakatsuyuki vaccinationandinfectionascausativefactorsinjapanesepatientswithrasmussensyndromemolecularmimicryandhlaclassi
AT osakahitoshi vaccinationandinfectionascausativefactorsinjapanesepatientswithrasmussensyndromemolecularmimicryandhlaclassi
AT akasakanoriyuki vaccinationandinfectionascausativefactorsinjapanesepatientswithrasmussensyndromemolecularmimicryandhlaclassi
AT imamuraatsushi vaccinationandinfectionascausativefactorsinjapanesepatientswithrasmussensyndromemolecularmimicryandhlaclassi
AT yamadashinji vaccinationandinfectionascausativefactorsinjapanesepatientswithrasmussensyndromemolecularmimicryandhlaclassi
AT kondonaomi vaccinationandinfectionascausativefactorsinjapanesepatientswithrasmussensyndromemolecularmimicryandhlaclassi
AT fujiwaratateki vaccinationandinfectionascausativefactorsinjapanesepatientswithrasmussensyndromemolecularmimicryandhlaclassi